drugset / Trial / NCT00004981

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

NCT00004981 ↗

Phase 3 Unknown 230 enrolled Glaxo Wellcome
Treatment

Summary

The purpose of this study is to look at the safety and effectiveness of a pill called Trizivir that is a combination of three anti-HIV drugs (zidovudine, lamivudine, and abacavir). Zidovudine and lamivudine are often given combined in one pill (Combivir). In this study, Trizivir will be compared to Combivir plus abacavir.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Abacavir Other / unclassified 300 mg —
Background Lamivudine Other / unclassified 150 mg Oral
Background Zidovudine Small molecule 300 mg Oral